Novo Nordisk (NYSE:NVO) reported quarterly earnings results on February 04, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.94, beating the consensus estimate of $0.89 by $0.05 per share. Revenue came in at $12.3B, beating the estimate of $12.1B.
Novo Nordisk's stock moved following the earnings release. The stock currently trades at $47.73 with a market capitalization of $223.5B.